Table: Garna Biosciences -2019 group results

Carna Biosciences

07/02/2020 06:30

Feb 7 (Reuters)- 
          Garna Biosciences Inc 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended       Year ended        Year to         NEXT   
                Dec 31, 2019     Dec 31, 2018     Dec 31, 2020      YEAR     
                   LATEST          YEAR-AGO         COMPANY        COMPANY   
                   RESULTS         RESULTS          FORECAST     H1 FORECAST 
  Sales             3.21           754 mln            1.04                   
                (+325.0 pct)     (+14.8 pct)      (-67.7 pct)                
  Operating        977 mln        loss 1.14        loss 1.78                 
  Recurring        957 mln        loss 1.16        loss 1.79                 
  Net
  Net              828 mln        loss 1.21        loss 1.82                 
  EPS             76.05 yen    loss 125.02 yen  loss 156.45 yen              
  EPS Diluted     74.51 yen                                                  
  Ann Div            NIL             NIL              NIL                    
  -Q2 Div            NIL             NIL              NIL                    
  -Q4 Div            NIL             NIL              NIL                    
  
  NOTE - Garna Biosciences Inc.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4572.T